Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.08B
Close$
$0.02
85.6% downside
Current Fair Value
85.6% downsideOvervalued by 85.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $-1,082,370,600.00 |
| Annual dividend | $0.00 |
| Dividend yield | 1.45% |
| Earnings per Share | $0.02 |
| Beta | 0.89 |
| Outstanding Shares | 9,027,695,000 |
Return
| Return on Equity | 3.58% |
|---|---|
| Return on Assets | 1.89% |
| Return on Invested Capital | 3.51% |
Valuation & Multiples
| P/E Ratio | 19.07 |
|---|---|
| PEG | 16.02 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.97 |
| Enterprise Value to EBIT | 16.46 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 1, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sihuan Pharmaceutical Holdings Group Ltd.
2,843 employees
CEO: Wei Cheng Guo
Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company that engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products. Its portfolio includes products for the cardio-...